COVID-19 PRECLINICAL STUDIES OF PHP-303, A NEUTROPHIL ELASTASE INHIBITOR TO TREAT SEVERE COVID-19 ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME AND LUNG INJURY
$1,503,866FY2021Defense Health AgencyDOD
Peak Bio Ca, Inc.
Investigators
View source on USAspending →COVID-19 PRECLINICAL STUDIES OF PHP-303, A NEUTROPHIL ELASTASE INHIBITOR TO TREAT SEVERE COVID-19 ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME AND LUNG INJURY · GrantIndex